US2020188459A1PendingUtilityA1

Process for preparing metabolized conditioned growth media

Assignee: ALLERGAN INCPriority: Nov 12, 2010Filed: Feb 4, 2020Published: Jun 18, 2020
Est. expiryNov 12, 2030(~4.3 yrs left)· nominal 20-yr term from priority
A61K 8/98A61K 8/99C12P 1/02A61K 8/9728A61P 31/10A61Q 19/08A61K 36/064A61Q 7/00A61Q 19/02A61P 17/14A61K 8/9789A61Q 19/001A61P 31/00A61Q 19/00A61K 35/33A61K 2800/522A61K 36/06A61P 17/18A61K 8/9706A61P 17/10A61P 17/16A61P 17/00
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions comprising metabolized conditioned growth medium and/or metabolized cell extract and methods of use are described. The metabolized conditioned growth medium and metabolized cell extract compositions may be formulated with an acceptable carrier into injectable or topical formulations, for example, as a cream, lotion or gel, and may be used in cosmeceutical or pharmaceutical applications. The metabolized conditioned growth medium and metabolized cell extract may also be further processed to concentrate or reduce one or more factors or components contained within the metabolized conditioned growth medium or metabolized cell extract. The growth medium may be conditioned by any eukaryotic cell. The metabolized conditioned growth medium and metabolized cell extract may be used to prevent or treat a condition, for example, a skin condition.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A topical composition comprising:
 metabolized cell extract; and   a suitable vehicle,   wherein the topical composition is obtainable by a process comprising the steps:
 (a) providing a fibroblast cell extract; 
 (b) culturing yeast cells; 
 (c) exposing the yeast cells to the fibroblast cell extract; 
 (d) culturing the yeast cells to metabolize at least a portion of the fibroblast cell extract; 
 (e) collecting the metabolized fibroblast cell extract; and 
 (f) combining the metabolized fibroblast cell extract with the suitable vehicle. 
   
     
     
         2 . The topical composition according to  claim 1 , further comprising at least one of water, surfactant, emulsifier, conditioner, emollient, wax, oil, polymer, thickener, fixative, colorant, nutraceutical, cosmeceutical, therapeutic, pharmaceutical, antifungal, antimicrobial, steroidal hormone, antidandruff agent, anti-acne component, sunscreen, and preservative. 
     
     
         3 . The topical composition according to any one of  claim 1  or  2 , wherein the topical composition is an ointment, a cream, a hydrogel, or a lotion. 
     
     
         4 . The topical composition according to  claim 1 , wherein the yeast is selected from a family selected from:  Neurospora, Ceratostomella, Claviceps, Xylaria, Rosellinia, Helotium, Sclerotinia, Tulostoma, Rhizopogon, Truncocolumella, Mucor, Rhizopus, Entomophthora, Dictostylium, Blastocladia, Synchytrium, Saprolegnia, Peronospora, Albugo, Pythium, Phytophthora, Plasmodiophora, Tuber, Hydnum, Lecanora, Roccella, Pertusaria, Usnea, Evernia, Ramalina, Alectoria, Cladonia, Parmelia, Cetraria, Agaricus, Cantharellus, Omphalotus, Coprinus, Lactarius, Marasmius, Pleurotus, Pholiota, Russula, Lactarius, Stropharia, Entoloma, Lepiotaceae, Corticium, Pellicularia, Tricholoma, Volvaria, Clitocybe, Flammulina, Saccharomyces, Schizosaccharomyces, Saccharomycetaceae, Eurotium, Aspergillus, Thielavia, Peziza, Plectania, Morchella, Wynnea, Helvella, Gyromitra, Phallales, Dictyophera, Mutinus, Clathrus, Pseudocolus, Lycoperdon, Calvatia, Geastrum, Radiigera, Astreus, Nidularia, Gastrocybe, Macowanites, Gastroboletus, Albatrellus, Neolentinus, Nigroporus, Oligoporus, Polyporus, Fistulina, Fomes, Boletus, Fuscoboletinus, Leccinum, Phylloporus, Suillus, Strobilomyces, Boletellus, Tremella, Auricularia, Dacrymyces, Melampsora, Cronartium, Puccinia, Gymnosporangium, Tilletia, Urocystis, Septobasidium, Hygrocybe, Hygrophorus, Hygrotrama, Neohygrophorus, Cortinarius, Gymnopilus, Trichophyton, Microsporum, Monilia, Candida, Cercosporella, Penicillium, Blastomyces, Cercospora, Ustilaginoidea, Tuber cularia, Fusarium, Rhizoctinia, Ozonium, Sclerotium, Geoglossum , and  Armillaria.    
     
     
         5 . The topical composition according to  claim 4 , wherein the yeast is selected from the family Saccharomycetaceae. 
     
     
         6 . The topical composition according to  claim 5 , wherein the yeast is selected from the genus  Pichia.    
     
     
         7 . The topical composition according to  claim 6 , wherein the yeast is selected from the species  pastoris.    
     
     
         8 . The topical composition according to  claim 1  for use in a method of therapy. 
     
     
         9 . The topical composition according to  claim 1  for use in a method of treating wounds. 
     
     
         10 . Use of the topical composition according to  claim 1  for the cosmetic treatment of a skin condition.

Join the waitlist — get patent alerts

Track US2020188459A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.